Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation and neurodegeneration, leading to a range of symptoms including muscle spasticity, pain, and mobility issues. Traditional treatments often fall short in fully alleviating these symptoms, prompting exploration of alternative therapies such as cannabis-based treatments. Cannabis and Its Components Cannabis contains over 100 cannabinoids, with tetrahydrocannabinol (THC) and cannabidiol (CBD) being the most studied.
THC is cbd products legal known for its psychoactive effects, while CBD is non-psychoactive and has been associated with anti-inflammatory and neuroprotective properties. Mechanisms of Action Cannabinoids interact with the endocannabinoid system (ECS), which plays a role in regulating pain, spasticity, and immune responses. By modulating ECS activity, cannabinoids may influence the progression and symptomatology of MS.
